UCL Institute of Neurology



Queen Square Inaugural Lectures

UCL Institute of Neurology is pleased to report on its latest set of inaugural lectures held on 21st September 2017

Publication date:

Professor Gill Bates appointed new Vice Dean (Research)

Professor Gill Bates (UCL Institute of Neurology) has been appointed as the new Vice Dean (Research) for the Faculty of Brain Sciences, as of 1st October 2016, and we warmly welcome her to the Faculty senior leadership team.

Professor Bates joined UCL in May 2016 as Professor of Molecular Neuroscience and Co-Director of the Huntington's Disease Centre in the Sobell Department of Motor Neuroscience (UCL Institute of Neurology). The research of the Bates lab is focussed on understanding the molecular basis of Huntington’s disease and developing therapeutic interventions.

Professor Bates will play a key role in shaping the Faculty’s research strategy and will work with Faculty leadership and the Office of the Vice Provost (Research) to ensure that Faculty and UCL objectives are aligned.  Throughout her career, she has demonstrated a genuine collegiate spirit and she is an inspiring role model to junior researchers. On her appointment, she said: “I am very excited to have been given this opportunity to play an active role in contributing to the Faculty and wider UCL research community.”

Professor Bates takes over this role from Professor Nick Wood, and will continue to build on the superb work that he has done over the past five years. Prof Wood skilfully aligned the Faculty research strategy with the UCLH/UCL BRC neurosciences themes, and contributed enormously to the successful renewal of the BRC funding. He has been a key member of the School Research Board, involved in the triage, peer review and mock interviews for large grant proposals, improving our success rate as a School, of these major grant applications. We are very grateful for all he has achieved.

Publication date:

New drug shows promise against muscle wasting disease

A new drug to treat the muscle wasting disease inclusion body myositis (IBM) reverses key symptoms in mice and is safe and well-tolerated in patients, finds a new study led by the Medical Research Council (MRC) Centre for Neuromuscular Diseases at University College London (UCL) Institute of Neurology and the University of Kansas Medical Center.

Publication date:

Professor Roger Lemon awarded the Fyssen International Prize 2015

We are delighted to announce that Professor Roger Lemon (Sobell Chair of Neurophysiology, UCL Institute of Neurology) has been awarded the Fyssen International Prize 2015 for his work in Neurocognitive Mechanisms in Sensory and Motor systems.

Publication date:

Deep brain stimulation for Tourette syndrome

In the largest trial ever performed, and recruiting the most severely affected patients with Tourette syndrome, researchers led by Dr Tom Foltynie, UCL Institute of Neurology, have shown that Deep Brain stimulation of an area of the brain called the globus pallidus (GPi) can lead to significant reduction in tic severity when stimulation is switched ON compared with when switched OFF.

Publication date:

UCL awarded £10m to develop new dementia treatments

Alzheimer’s Research UK today announced a £30m Drug Discovery Alliance, launching three flagship Drug Discovery Institutes at UCL, the University of Cambridge and the University of Oxford. The Drug Discovery Institutes will see 90 new research scientists employed in state-of-the-art facilities to fast-track the development of new treatments for Alzheimer’s disease and other dementias.

Publication date:

Light-activated neurons from stem cells restore function to paralysed muscles

A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King’s College London, co-led by Professor Linda Greensmith of the MRC Centre for Neuromuscular Diseases at UCL’s Institute of Neurology.

Publication date:

Brain Implant Cures Woman's Tourette's Tics

A patient who is part of the first first UK trial to evaluate the impact of 'deep brain stimulation' on Tourette's - a collaboration between the UCL Institute of Neurology (Unit of Functional Neurosurgery) and the National Hospital of Neurology and Neurosurgery - has experienced a dramatic recovery.

Publication date: